Nuvectis Pharma, Inc./$NVCT
1D1W1MYTD1Y5YMAX
About Nuvectis Pharma, Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
- Ticker
- $NVCT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 16
- Headquarters
- Fort Lee, United States
- Website
- www.nuvectis.com
NVCT Metrics
BasicAdvanced
$798M
-
-$1.30
-0.26
-
Price and volume
Market cap
$798M
Beta
-0.26
52-week high
$29.28
52-week low
$5.55
Average daily volume
212K
Financial strength
Current ratio
1.683
Quick ratio
1.667
Profitability
Management effectiveness
Return on assets (TTM)
-73.07%
Return on equity (TTM)
-214.58%
Valuation
Price to book
71.98
Price to tangible book (TTM)
71.98
Price to free cash flow (TTM)
-29.131
Free cash flow yield (TTM)
-3.43%
Free cash flow per share (TTM)
-0.841
Growth
Earnings per share change (TTM)
12.77%
3-year earnings per share growth (CAGR)
-5.07%
NVCT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.